Y-Intercept (HK)’s ClearPoint Neuro CLPT Stock Holding History

Y-Intercept (HK)’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-79,650	Closed	-$429K	–	1365
2024 Q2	$429K	Buy	+79,650	New	+$461K	0.02%	887

Other funds holding CLPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CWM

Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Y-Intercept (HK)'s CLPT Position: Q3 2024 in Review

Y-Intercept (HK) sold out of ClearPoint Neuro (CLPT) in Q3 2024, closing a stake of 79,650 shares — an estimated $429K sold.

Y-Intercept (HK) first reported a position in CLPT in Q2 2024 and held it in 1 quarter. The position peaked at $429K in Q2 2024. 78 funds tracked by Wall St. Rank hold CLPT as of Q3 2024.

Y-Intercept (HK) reported no remaining ClearPoint Neuro position as of Q3 2024 after selling out during the quarter.
Y-Intercept (HK) sold 79,650 ClearPoint Neuro shares in Q3 2024, an estimated $429K.
Y-Intercept (HK) first reported a position in ClearPoint Neuro in Q2 2024 and held it in 1 quarter.
Y-Intercept (HK)'s ClearPoint Neuro position peaked at $429K in Q2 2024.
78 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.